SCHEMBL17477115

SCHEMBL17477115

COC(=O)c1ccc(Sc2ccc(N)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.55
HPGD P15428 6/20 0.55
ALDH1A1 P00352 6/20 0.55
KDM4E B2RXH2 5/20 0.55
LMNA P02545 5/20 0.55
L3MBTL1 Q9Y468 3/20 0.55
MAPK1 P28482 3/20 0.55
HSD17B10 Q99714 3/20 0.55
ALOX15 P16050 2/20 0.55
NPSR1 Q6W5P4 1/20 0.54
CYP3A4 P08684 2/20 0.52
TSHR P16473 2/20 0.52
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
CA12 O43570 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
GAA P10253 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6575703 0.90 CA1 (0.61) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL42732 0.88 CA1 (0.64) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL28108955 0.86 CA1 (0.61) MAPTHPGDALDH1A1KDM4ELMNA
Hydrochloric Acid SCHEMBL8359634 0.86 CA1 (0.61) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL6935338 0.83 CA1 (0.77) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL20591202 0.83 TDP1 (0.77) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL5887658 0.83 TSHR (0.67) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL929744 0.83 MAPT (0.57) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL14937438 0.82 MAPT (0.50) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL7908252 0.82 CA1 (0.57) MAPTHPGDALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3180307-B1 PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES SEEGPHARM SA (CH) 2019-02-13 EP disclosed
US-9845289-B2 Process for the synthesis of Dapsone and its intermediates SEEGPHARM SA (CH) 2017-12-19 US disclosed
US-20170217883-A1 PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES SEEGPHARM SA (CH) 2017-08-03 US disclosed
EP-3180307-A1 PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES Seegpharm SA (CH) 2017-06-21 EP disclosed
WO-2016016321-A1 PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES SEEGPHARM SA (CH) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217883-A1 PROCESS FOR THE SYNTHESIS OF DAPSONE AND ITS INTERMEDIATES DHPS, FDPS, DAP3 MAPT 3725/4885HPGD 59/4885ALDH1A1 1853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.